2008, Number S1
<< Back Next >>
Rev Mex Anest 2008; 31 (S1)
Colloids in cardiac surgery
Fernández-Rivera BJ
Language: Spanish
References: 7
Page: 127-128
PDF size: 80.15 Kb.
Text Extraction
No abstract
REFERENCES
Luna P. Terapéutica de volumen en cirugía cardíaca. En: Luna P (ed). Anestesia Cardiovascular, México D.F. MacGraw-Hill Interamericana. 2005:627-635.
Vincent JL. The pros and cons of hydroxyethyl starch solutions. Anesth Analg 2007;104:484-486.
Knutson JE, Deering JA, Hall FW, Darrell GA, Schroeder R, White RD, Mullany CJ. Does intraoperative hetastarch administration increase blood loss and transfusion requirements after cardiac surgery? Anesth Analg 2000;90:801–807.
Kasper SM, Meinert P, Kampe S, Görg C, Geisen C, Uwe Mehlhorn, Diefenbach C. Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery Bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. Anesthesiology 2003;99:42–47.
Kuitunen AH, Hynynen MJ, Vahtera E, Phil L, Markku T. Salmenpera, hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesth Analg 2004;98:291–297.
Grocott MPW, Mythen MG, Gan TJ, Perioperative fluid management and clinical outcomes in adults. Anesth Analg 2005;100:1093–1106.
Lang JD Jr, Figueroa M, Chumley P, Aslan M, Hurt J, Tarpey MM, Álvarez B, Radi R, Freeman BA. Albumin and hydroxyethyl starch modulate oxidative inflammatory injury to vascular endothelium. Anesthesiology 2004;100:51–58.